bosentan anhydrous has been researched along with Foot Ulcer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akamata, K; Asano, Y; Hatano, M; Ichimura, Y; Kawashima, T; Kinugawa, K; Miyazaki, M; Noda, S; Sato, S; Sugita, M; Sumida, H; Takahashi, T; Tamaki, Z; Taniguchi, T; Tomita, M; Toyama, T; Yao, A | 1 |
1 other study(ies) available for bosentan anhydrous and Foot Ulcer
| Article | Year |
|---|---|
Effects of bosentan on nondigital ulcers in patients with systemic sclerosis.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Bosentan; Dermatologic Agents; Female; Foot Ulcer; Humans; Hypertension, Pulmonary; Middle Aged; Off-Label Use; Scleroderma, Systemic; Sulfonamides; Treatment Outcome; Wound Healing | 2012 |